SESSION 1
New pathway and targets in diffuse large B cell lymphoma
R. Dalla Favera
Advances in the treatment for relapsed-refractory diffuse large B cell lymphoma
C. Carlo-Stella
SESSION 2
New perspectives in relapsed-refractory diffuse mantle cell lymphoma
O. Hermine
Central nervous system lymphoma: novel approaches?
T. Calimeri
SESSION 3
CAR-CIK
F. Lussana
Current challenges and emerging opportunities after CAR- T therapies
G. Gritti
CAR-T in multiple myeloma
B. Bruno
Privacy Policy
|
Cookie Policy
×
